Rebecca Cogswell1, Marc Pritzker2, Teresa De Marco3. 1. Division of Cardiology, University of Minnesota, Minneapolis, Minnesota. Electronic address: cogsw014@umn.edu. 2. Division of Cardiology, University of Minnesota, Minneapolis, Minnesota. 3. Division of Cardiology, University of California, San Francisco.
Abstract
BACKGROUND: The REVEAL model for pulmonary arterial hypertension (PAH) uses 19 predictors to calculate a 1-year survival probability and can be repeated over time. It is currently unclear which of the 19 variables are the most essential for serial REVEAL score calculation. We aimed to identify high-yield predictors in the REVEAL score and hypothesized that the model could be simplified considerably without compromising performance. METHODS: REVEAL scores were calculated in a cohort of 140 PAH patients (Full REVEAL Model). Scores were then recalculated excluding all right heart catheterization and pulmonary function test data (Simple Model) and again using only PAH type, New York Heart Association class, brain natriuretic peptide, renal function and right atrial pressure by echocardiogram (Clinical Model). The models were then tested for the ability to predict 1-year outcomes and the performance of the models was compared. RESULTS: The c indices of the models to predict 1-year survival were not statistically different from one another (Full REVEAL Model: 0.765; Simple Model: 0.759; Clinical Model: 0.745; p = 0.92). For the composite outcome of survival or freedom from lung transplant at 1 year, the models were again not statistically different from one another (c indices: Full REVEAL Model: 0.805; Simple Model: 0.809; Clinical Model: 0.785; p = 0.73). CONCLUSIONS: The original, Full REVEAL Model appeared to have comparable performance after selectively limiting the number of predictors. There is opportunity to re-evaluate large-registry PAH data to identify a limited number of high-yield variables and to develop a simplified, clinical model.
BACKGROUND: The REVEAL model for pulmonary arterial hypertension (PAH) uses 19 predictors to calculate a 1-year survival probability and can be repeated over time. It is currently unclear which of the 19 variables are the most essential for serial REVEAL score calculation. We aimed to identify high-yield predictors in the REVEAL score and hypothesized that the model could be simplified considerably without compromising performance. METHODS: REVEAL scores were calculated in a cohort of 140 PAH patients (Full REVEAL Model). Scores were then recalculated excluding all right heart catheterization and pulmonary function test data (Simple Model) and again using only PAH type, New York Heart Association class, brain natriuretic peptide, renal function and right atrial pressure by echocardiogram (Clinical Model). The models were then tested for the ability to predict 1-year outcomes and the performance of the models was compared. RESULTS: The c indices of the models to predict 1-year survival were not statistically different from one another (Full REVEAL Model: 0.765; Simple Model: 0.759; Clinical Model: 0.745; p = 0.92). For the composite outcome of survival or freedom from lung transplant at 1 year, the models were again not statistically different from one another (c indices: Full REVEAL Model: 0.805; Simple Model: 0.809; Clinical Model: 0.785; p = 0.73). CONCLUSIONS: The original, Full REVEAL Model appeared to have comparable performance after selectively limiting the number of predictors. There is opportunity to re-evaluate large-registry PAH data to identify a limited number of high-yield variables and to develop a simplified, clinical model.
Authors: Gabriela Querejeta Roca; Patricia Campbell; Brian Claggett; Scott D Solomon; Amil M Shah Journal: Circ Cardiovasc Imaging Date: 2015-11 Impact factor: 7.792
Authors: James C Coons; Kristen Pogue; Andrew R Kolodziej; Glenn A Hirsch; Marjorie Patricia George Journal: Curr Cardiol Rep Date: 2019-11-22 Impact factor: 2.931
Authors: Nazzareno Galiè; Richard N Channick; Robert P Frantz; Ekkehard Grünig; Zhi Cheng Jing; Olga Moiseeva; Ioana R Preston; Tomas Pulido; Zeenat Safdar; Yuichi Tamura; Vallerie V McLaughlin Journal: Eur Respir J Date: 2019-01-24 Impact factor: 16.671
Authors: Masataka Kuwana; Christiana Blair; Tomohiko Takahashi; Jonathan Langley; John G Coghlan Journal: Ann Rheum Dis Date: 2020-03-11 Impact factor: 19.103
Authors: Marcelo M Mello; Guilherme Watte; Stephan Altmayer; Yana L R Pallaoro; Fernanda B Spilimbergo; Daniela C Blanco; Gisela M B Meyer; Edson Marchiori; Bruno Hochhegger Journal: Radiol Bras Date: 2019 Nov-Dec